Early research examines potential benefits of stem cell transplants in advanced SM
Stem cell transplantation can reduce disease activity for people with advanced systemic mastocytosis (SM) and may help patients live longer.
Stem cell transplantation can reduce disease activity for people with advanced systemic mastocytosis (SM) and may help patients live longer.
HT-KIT, a new treatment for SM and other cancers, has shown promising results in early laboratory studies.
Major progress has been made in the treatment of SM, but patients with the most aggressive forms of the disease still need better options.
A woman with difficulty swallowing and weight loss was initially thought to have a gastrointestinal condition, but was later diagnosed with SM.
There have been significant advances in the diagnosis and treatment of indolent SM in recent years, although more research is still necessary.
A new treatment called bezuclastinib has shown promise in reducing symptoms of non-advanced systemic mastocytosis.
A man with acute myeloid leukemia was also diagnosed with systemic mastocytosis after late bone marrow tests.
Vitamin supplements may help relieve chronic itch in people with conditions like systemic mastocytosis, especially when applied topically.
A man with systemic mastocytosis experienced a severe allergic reaction and eventually died after being stung by a wasp.